image.png
Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson’s Trial
January 30, 2025 08:00 ET | Jupiter Neurosciences, Inc.
Jupiter, Florida, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a patented...
Picture1.jpg
Health Catalyst to Participate in Upcoming Investor Conference
January 30, 2025 08:00 ET | Health Catalyst, Inc.
SALT LAKE CITY, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare...
ZimVie_Logo.png
ZimVie Announces Publication of a Study Supporting the Benefits of Its Implant Surface Technologies
January 30, 2025 08:00 ET | ZimVie Inc.
PALM BEACH GARDENS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced the publication of a detailed...
Keros (2).jpg
Keros Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference
January 30, 2025 08:00 ET | Keros Therapeutics, Inc.
LEXINGTON, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel...
pyxis_logo.png
Pyxis Tankers Announces Completion of Common Share Repurchase Program & Update on Chartering Activity
January 30, 2025 08:00 ET | Pyxis Tankers Inc.
Maroussi, Greece – January 30, 2025 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), (“we”, “our”, “us”, the “Company” or “Pyxis Tankers”), an international shipping company, announced today key...
ALLARITY Full Color RGB 2023JUN07.png
Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC
January 30, 2025 08:00 ET | Allarity Therapeutics, Inc.
Boston (January 30, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer...
Alpha (1).jpg
Alpha Modus CEO Addresses Market Volatility and its Recent SPAC Merger
January 30, 2025 08:00 ET | Alpha Modus Corp.
CORNELIUS, N.C., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (Nasdaq: AMOD) (“Alpha Modus”, “AMOD”, or the “Company”), in a statement today, through Alpha Modus CEO William Alessi,...
Veriff Boosts Growth for Startups and SMBs with Streamlined Identity Verification via Zapier
January 30, 2025 08:00 ET | Veriff
New York, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Veriff, a global identity verification and authentication platform, today launched its App for Zapier, empowering businesses to automate verification...
royaland.jpg
The RoyaLand Company Ltd. Introduces a New Mobile Companion App for TheRoyal.Land
January 30, 2025 08:00 ET | THE ROYALAND COMPANY LTD.
Hamilton, Bermuda and Paris, France, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The RoyaLand Company Ltd. (OTCQB: RLNDF) (“RoyaLand” or the “Company”), a Bermuda holding company focused on creating an online...
Indicium Launches Unity Catalog Migration Solution for Databricks Customers
January 30, 2025 08:00 ET | Indicium
NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Indicium, a global data services consultancy, announces the Unity Catalog Migration, a new solution enabling unified governance of data and AI assets...